Drug intelligence / Profile preview

TRFK-5

Development stage
Preclinical
Lead developer
Merck
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intraperitoneal, Intravenous
01

Overview

TRFK-5 is a rat-derived IgG1 monoclonal antibody that specifically targets and neutralizes interleukin-5 (IL-5). IL-5 is a key cytokine responsible for the maturation, differentiation, and recruitment of eosinophils, which are central to the pathophysiology of allergic asthma and other eosinophilic inflammatory conditions. By binding to IL-5, TRFK-5 prevents the cytokine from interacting with its receptor on eosinophil precursors and mature cells, thereby inhibiting pulmonary eosinophilia and reducing airway hyperreactivity. Developed and utilized extensively in preclinical research by Schering-Plough and academic institutions, TRFK-5 has served as a critical tool in murine and non-human primate models to validate IL-5 as a therapeutic target for respiratory diseases.

Other names
rat anti-mouse IL-5 monoclonal antibodyanti-IL-5 antibodyanti-IL5 antibodyanti-IL 5 antibody
02

Targets

IL-5 (Interleukin 5)

Beyond the preview

Go deeper on TRFK-5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRFK-5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call